Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia

Yii, Yong-ChengYong-ChengYiiShih, Hong-MoHong-MoShihChen, Chieh-LungChieh-LungChenLai, Zi-LunZi-LunLaiHsu, Yu-LungYu-LungHsuLai, Chia-HongChia-HongLaiPO-REN HSUEHCho, Der-YangDer-YangCho2024-02-072024-02-072024-0109248579https://scholars.lib.ntu.edu.tw/handle/123456789/639675This study aimed to evaluate the effect of administering nirmatrelvir/ritonavir and molnupiravir before hospitalisation on subsequent critical illness among patients with COVID-19 pneumonia.enCOVID-19; Critical illness; Molnupiravir; Nirmatrelvir/ritonavir; Oral antivirals; VaccineEffect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumoniajournal article10.1016/j.ijantimicag.2023.107020378983652-s2.0-85178350895https://api.elsevier.com/content/abstract/scopus_id/85178350895